Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan 20;22(1):45-51.
doi: 10.3779/j.issn.1009-3419.2019.01.09.

[Research Advances of JAK/STAT Signaling Pathway in Lung Cancer]

[Article in Chinese]
Affiliations
Review

[Research Advances of JAK/STAT Signaling Pathway in Lung Cancer]

[Article in Chinese]
Xin Yang et al. Zhongguo Fei Ai Za Zhi. .

Abstract

Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway is one of the downstream pathways of cytokine signaling transduction. It regulates cell development, differentiation, proliferation, apoptosis and so on. The pathway is not only involved in the regulation of normal physiological processes, but also significant in the development of tumors, especially in hematologic malignancies. In recent years, with the further research of JAK/STAT signaling pathway, it has been found that the pathway also plays a key role in the development of solid tumors. Here we reviewed the research advances of JAK/STAT signaling pathway in lung cancer, especially the mechanisms of development, metastasis and drug resistance, and the application of inhibitors which targeting JAK/STAT signaling pathway in the treatment of lung cancer. .

【中文题目:JAK/STAT信号通路在肺癌中的研究进展】 【中文摘要:Janus激酶(Janus kinase, JAK)/信号转导子和转录活化子(signal transducer and activator of transcription, STAT)信号通路是细胞因子信号传导的下游通路,调控细胞的发育、分化、增殖、凋亡等,不仅参与调节正常的生理过程,在肿瘤的发生发展中也起着重要作用,尤其是在血液系统肿瘤中意义重大。近年来,随着对JAK/STAT信号通路研究的深入,人们发现该通路在实体肿瘤的发生发展中也扮演关键角色。本文就近年来JAK/STAT信号通路参与肺癌发生发展、肺癌转移、肺癌耐药机制形成以及靶向该通路的抑制剂在肺癌治疗中的应用现状进行综述。】 【中文关键词:JAK-STAT信号通路;肺肿瘤;耐药;抑制剂】.

Keywords: Drug resistance; Inhibitors; JAK/STAT signaling pathway; Lung neoplasms.

PubMed Disclaimer

Figures

1
1
JAK/STAT信号通路 The signaling pathways of JAK/STAT

Similar articles

Cited by

References

    1. O'Shea JJ, Holland SM, Staudt LM. JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med. 2013;368(2):161–170. doi: 10.1056/NEJMra1202117. - DOI - PMC - PubMed
    1. Tan WL, Jain A, Takano A, et al. Novel therapeutic targets on the horizon for lung cancer. Lancet Oncol. 2016;17(8):e347–e362. doi: 10.1016/S1470-2045(16)30123-1. - DOI - PubMed
    1. Leonard WJ, O'Shea JJ. Jaks and STATs: biological implications. Annu Rev Immunol. 1998;16:293–322. doi: 10.1146/annurev.immunol.16.1.293. - DOI - PubMed
    1. Xu Y, Jin J, Xu J, et al. JAK2 variations and functions in lung adenocarcinoma. Tumour Biol. 2017;39(6):1010428317711140. doi: 10.1177/1010428317711140. - DOI - PubMed
    1. Li SD, Ma M, Li H, et al. Cancer gene profiling in non-small cell lung cancers reveals activating mutations in JAK2 and JAK3 with therapeutic implications. Genome Med. 2017;9(1):89. doi: 10.1186/s13073-017-0478-1. - DOI - PMC - PubMed

MeSH terms